RxDoctor Payments Data

John McSweeney

Adult Health · Phoenix, AZNPI 1124080858

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.8% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,960 and has fallen 83.9% since, to $316 in 2025.

$3,922in general payments, 2019–2025

Across 192 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$489
  • AstraZeneca$277
  • Seagen Inc.$265
  • Amgen$232
  • Johnson & Johnson$229
  • Merck$222
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,79597%
  • Education$1273%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,922 in reported general payments places this provider in the 85th percentile of 314 adult health providers in Arizona.

See all adult health providers in Arizona

Other adult health in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →